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Chapter 1 INTRODUCTION 
Description of Problem 
 Over the past two decades, dysautonomia, or conditions marked by dysfunction of the 
autonomic nervous system, have been gaining more attention (Grubb, 2008; Grubb, Kanjwal, & 
Kosinski, 2006).  Postural orthostatic tachycardia syndrome (POTS) is one form of 
dysautonomia that has been gaining such attention.  Differing opinions on exact diagnostic 
criteria and other features of the syndrome exist in the medical community, making the need for 
further research more evident (Abed, Ball, & Wang, 2012).  Because of the incomplete 
understanding of POTS in the medical community and the complex and heterogeneous nature of 
the syndrome, POTS patients must advocate for themselves and continue to fight against 
dysautonomia.  Therefore, there is a need for increased dysautonomia, and specifically POTS, 
education, awareness, and support for the patient population, loved ones of those who live with 
POTS, healthcare providers, and the general population. 
Background 
 Several authors have estimated that approximately 500,000 to 1,000,000 individuals in 
the United States, alone, have POTS, however there are varying estimates including statements 
of the prevalence being unknown (Low, Sandroni, Joyner, & Shen, 2009; Abed, Ball, & Wang, 
2012; Grubb, 2008).  Women of childbearing age, between approximately 13 and 50 years old, 
are affected more often than men (Abed et al., 2012; Benarroch, 2012; Raj & Levine, 2013).  The 
female-to-male ratio is about 5:1 (Abed et al., 2012; Benarroch, 2012). 
 As previously stated, POTS is one type of dysautonomia.  The autonomic nervous system 
is responsible for the involuntary functions in the body such as constriction and dilation of blood 
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vessels as well as heart beat (ANS Disorders, n.d.).  POTS is marked by an inappropriate and 
inadequate autonomic response to changes in posture from supine to standing. 
 When an individual with an appropriate and healthy autonomic nervous system stands up, 
gravity causes a shift in the blood volume toward the lower body resulting in a slight increase in 
heart rate to pump the blood back up to the heart and other organs (Abed et al., 2012).  The fully 
functional autonomic system compensates very quickly for the change in posture and heart rate 
remains stable with only minimal changes.  The individual remains unconscious of the 
compensatory activity occurring and continues feeling well as homeostasis and balance are 
maintained.   
 Individuals with POTS, on the other hand, have a dysfunctional autonomic nervous 
system that does not react properly.  When individuals with POTS stand up gravity pulls much of 
the blood volume into the legs and lower body and away from the vital organs such as the heart 
and brain (Grubb, 2008).  Since these individuals do not have an autonomic nervous system that 
is working properly an imbalance occurs as the system attempts to compensate for this shift in 
blood volume by significantly increasing the heart rate to try and keep the vital organs perfused.  
As the body senses this decrease in blood flow to vital organs, signs and symptoms suggestive of 
hypoperfusion occur, such as lightheadedness, syncope or near syncope, tachycardia, 
palpitations, nausea, and diminished concentration.  Once the individual sits or lies down and 
orthostatic stress is removed, or at least diminished, symptoms usually improve.  It is important 
to note that many POTS patients report other varying symptoms that are not related to orthostatic 
stress which cause a more complex and difficult clinical picture and often affect diagnosis and 
management (Benarroch, 2012). 
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Categorization of POTS 
 Researchers and authors have proposed several ways to classify and describe POTS by 
sorting cases into subtypes or groups.  Because there is not yet one single consistent method of 
identifying subtypes, and many patients present with features of more than one “type”, it seems 
best to simply describe some of the common features that exist within each group and leave 
some classification open to self-interpretation.  There are cases, however, in which even the 
categorization that is described here is not entirely consistent.  That will be discussed briefly later 
in this paper.  The bottom line is that continued research is needed on POTS patients in order to 
gain a deeper understanding of the condition and the relationships between the many variables 
involved and in order to establish more standardized concepts and definitions. 
 Primary.  POTS can be categorized as being either a primary or secondary form of the 
condition (Grubb, 2008; Grubb et al., 2006).  The primary form of POTS is not associated with 
any other known disease but instead due to a dysautonomic process, whereas the secondary form 
of POTS is secondary to some other known underlying illness or disease and results in the 
syndrome of signs and symptoms characteristic of POTS.  The most common primary form of 
POTS is due to a type of peripheral autonomic neuropathy causing the vessels in the periphery 
not to constrict appropriately in response to orthostatic stress (Grubb, 2008; Grubb et al., 2006; 
Benarroch, 2012).  This neuropathic, or partial dysautonomic, process is the most common 
process found and often has an abrupt onset after a viral illness or some other precipitating event 
such as pregnancy, surgery, trauma, sepsis, immunizations, or some other traumatic or stressful 
event (Conner, Sheikh, & Grubb, 2012; Grubb et al., 2006).  At the current level of 
understanding and research, the neuropathic partial dysautonomic process causing POTS is 
thought to be caused by an immune-mediated response. 
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 Another group of patients who are thought to have a partial dysautonomia process 
responsible for POTS is a developmentally presenting group.  These cases are adolescents who 
develop POTS during the rapid growth of the teen years.  It is thought to be caused by a 
temporary imbalance in the autonomic system due to the rapid adolescent changes (Conner et al., 
2012; Grubb et al., 2006).  A majority, around 80%, of these developmentally based cases seem 
to outgrow the syndrome and make a full or near-full recovery by young adulthood, usually 
around the 19-24 year old range.   
 A rarer primary form is the hyperadrenergic POTS.  In the truest and purest sense of the 
term, hyperadrenergic POTS is a much less common form accounting for only about 10% of 
cases (Raj, 2006).  These patients experience an overabundance of sympathetic activity and 
norepinephrine levels >600 pg/ml, often even >1000-2000 pg/ml (Raj, 2006; Grubb et al., 2006; 
Conner et al., 2012; Grubb, 2008; Benarroch, 2012).  Patients often develop the hyperadrenergic 
form gradually and progressively, and it is thought to be caused by a genetic mutation causing an 
inappropriate overabundance of norepinephrine due to dysfunction of the reuptake transporter 
protein.  The body is unable to clear that norepinephrine from the intrasynaptic cleft leaving the 
patient with elevated serum catecholamine levels and symptoms of excessive sympathetic 
activity.   
 Many POTS patients experience multiple pathophysiological processes and may fit the 
criteria for multiple processes.  For instance, a patient may fit the neuropathic criteria but also 
have a standing norepinephrine level >600, or even greater than 1,000, but without known 
evidence of the genetic mutation.  Many POTS patients do experience elevated norepinephrine 
levels, and some authors and researchers even argue that standing norepinephrine levels must be 
>600 pg/ml for any diagnosis of POTS.  However, other authors believe that this finding is 
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consistent only in hyperadrenergic POTS (Conner et al., 2012; Grubb, 2008; Benarroch, 2012; 
Grubb, 2006).  Thus, what one physician might call a hyperadrenergic case of POTS, another 
might simply call a neuropathic case. 
 Secondary.  Patients that have the secondary form of POTS have some other underlying 
illness or disease, such as diabetes, Sjogren’s syndrome, or Lupus (Grubb et al., 2006).  Chronic 
diabetes mellitus, for instance, can cause peripheral neuropathy resulting in improper or absent 
peripheral autonomic function, causing loss of proper peripheral vasoconstriction in response to 
orthostatic stress, thus causing the signs and symptoms.   
 Mast cell activation disorders such as mast cell activation syndrome (MCAS) have also 
been linked to POTS, most specifically to a secondary form of hyperadrenergic POTS 
(Benarroch, 2012).  Mast cell disorders are either proliferative (too many mast cells accumulating 
in tissue or organs, as in mastocytosis) or activation based (the correct number, but overactive 
mast cells, as in MCAS) (Shibao et al., 2005). The histamine and other mast cell mediators are 
released in response to orthostatic or other stressors, causing the vessels to dilate and peripheral 
blood to pool, as in other types of POTS.  In addition, the body then experiences an increased 
sympathetic discharge.  There has been discussion on whether the mast cell response initiates the 
increase in sympathetic activity or whether the increase in sympathetic activity initiates the mast 
cell response.  Either way, the end result is the same: POTS symptoms in addition to flushing 
episodes, marked with increased urine methylhistamine levels, and other symptoms such as 
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Purpose 
 As already discussed, several pathological processes may be coexistent, and thus it is 
very difficult to describe universal comprehensive subtypes.  This confusion, lack of consistent 
phrasing and description, and need for further research has caused a mixed response from the 
medical and patient communities.  Many medical providers are unknowledgeable about POTS, 
not to mention proper treatment and discussion of various “types”.  Patients are left frustrated, 
confused, and feeling hopeless.  Patients are often misdiagnosed as having anxiety or panic 
disorders (Grubb et al., 2006).   
 Through personal experience with POTS, this author has become aware of the need for 
further awareness, education, and support for patients, families, and healthcare providers dealing 
with POTS.  The remainder of this paper will discuss current research literature and describe the 
project which is aimed at educating, increasing awareness, and providing support for those 
impacted or affected, either personally or indirectly, by POTS. 
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Chapter 2 LITERATURE REVIEW 
Research Literature 
Sleep and Quality of Life  
 Bagai et al. (2011), of Vanderbilt University, assessed (a) health-related quality of life, 
(b) fatigue, and (c) sleep quality in POTS patients, in comparison to healthy control subjects, by 
using a series of scales and questionnaires.  A total of 90 participants were included in the study:  
44 POTS patients who met the criteria for POTS diagnosis and 46 healthy control subjects 
recruited through a research volunteer database and advertisements within the local campus 
community. 
 Several tools were utilized during data collection.  Bagai et al. (2011) used the Medical 
Outcomes Study Sleep Scale comprised of 12 questions in order to assess difficulties within 
several areas of sleep:  snoring, sleep adequacy, sleep disturbance, headache, somnolence, and 
respiratory impairment.  Each area is scored on a scale of 0-100, with a higher score for sleep 
adequacy indicating improved and better sleep, and a higher score on any of the other areas 
indicating increased dysfunction.  The Epworth Sleepiness Scale ranging from 0 to 3, with a total 
possible score of 24, assesses subjective daytime sleepiness.  Eight common situations of daily 
living are presented and respondents must indicate the likeliness of sleeping in each situation.  
Responses >10 are usually seen in individuals with diagnosed sleep disorders affecting daytime 
sleepiness, whereas responses <10 are considered normal.  The Fatigue Visual Analogue Scale is 
a one question assessment of fatigue severity and uses a scale of 0-10, the higher responses 
indicating higher levels of fatigue.  The RAND-36 is a more general questionnaire assessing 
quality of life in 8 domains:  “physical functioning, role limitations caused by physical health 
problems, bodily pain, general health, emotional well-being, role limitations due to emotional 
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problems, social functioning, and energy/fatigue” (Bagai et al., 2011, p. 205).  A 0-100 scale is 
used, asking participants to rate in each area over the last four weeks.  Poorer quality of life is 
indicated by lower scores.  Lastly, the EuroQol was used to collect subjective rating for level of 
problem within 5 areas relating to health:  mobility, anxiety/depression, usual activities, self-
care, and pain/discomfort.  Participants rated each as either “no problem, some/moderate 
problems, or extreme problems” but results “were analyzed as dichotomous variables (no 
problems vs. some/moderate/extreme problems)” (p. 205).   
 The Medical Outcomes Sleep Scale found significantly poorer sleep adequacy and 
increased sleep difficulties in POTS patients than were found in the control subjects (Bagai et al., 
2011).  The Epworth Sleepiness Scale found a significant difference between POTS patients and 
control subjects.  Fifty-one percent of POTS patients scored >10, indicating excessive daytime 
sleepiness, in comparison with 16% of control subjects scoring above the same mark.  The 
Fatigue Visual Analogue Scale found that a significantly higher number of POTS patients, in 
comparison to healthy controls, indicated fatigue being a major issue within the past seven days.  
The RAND-36 and EuroQol both indicated significantly poorer “health-related quality of life” in 
POTS patients than in the control subjects.  The physical health scores were lower than were the 
mental health related scores (Bagai et al., 2011, p. 206). 
 Overall, Bagai et al. (2011) found that POTS patients experience more fatigue and sleep 
related difficulties than do healthy control subjects.  Furthermore, these sleepiness and fatigue 
related difficulties are related to poorer quality of life.  Interestingly, results showed that physical 
health was affected more than mental health, and because the control group scored worse in the 
snoring category, the authors have assumed that the self-reporting nature of the study, viewed as 
a possible limitation, did not in fact cause over-reporting of symptoms in the POTS group.  Bagai 
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et al. (2011) recommend further studies on this topic and involvement of more formal and 
objective methods to further understand the findings. 
Inattention and Psychiatric Disorders 
 Vidya Raj et al. (2009) used a cross-sectional controlled method to assess anxiety, 
attention, and mood in POTS patients (N=21) compared to ADHD participants (N=18) and 
normal control subjects (N=20) with no history of psychiatric or attention disorders.  Previously 
validated and commonly used questionnaires were used.  POTS patients met the diagnostic 
criteria for POTS, were tested while in the sitting position, were not currently taking any 
medications affecting psychiatric or autonomic function, and were asymptomatic during testing.  
Comparisons were done between two matched groups:  POTS patients with ADHD participants, 
and POTS patients with normal control subjects with no history of attention or psychiatric 
diagnoses.  Significance was set at the P<0.05 level. 
 Results showed that POTS patients did not experience significantly higher rates of 
anxiety disorders in comparison to the normal control subjects or those with ADHD (Vidya Raj 
et al., 2009).  Similarly, POTS patients did not show a greater “lifetime prevalence of major 
depressive disorder” in comparison with the normal control subjects (p. 4).  The ADHD 
participants, however, did show higher incidence of depressive disorders than both the normal 
control group and the POTS patients.  POTS patients also showed no significant differences in 
substance dependence and abuse in comparison to the normal control group. 
 Significant differences were found among the groups for scores on the second edition of 
the Beck Depression Inventory for degree of depression symptoms (Vidya Raj et al., 2009).  
Both POTS patients and ADHD participants scored higher in comparison with the control group 
for “magnitude of current depression symptoms” (p. 4).  The difference between POTS and 
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ADHD scores, however, were not significant.  The Beck Anxiety Inventory showed significantly 
higher scores in POTS patients in comparison with both the control subjects and those with 
ADHD.  The Anxiety Sensitivity Index showed significantly higher fear of anxiety related 
symptoms in the ADHD and POTS groups in comparison with the normal controls, however in 
comparison with the general population, POTS patients actually scored lower and ADHD 
subjects still scored higher.   
 The Connors Adult ADHD Rating Scale showed that POTS patients experienced 
significantly higher scores in comparison with the control subjects in three areas:  
inattention/memory problems, ADHD score, and ADHD index (Raj Vidya et al., 2009).  
However, those participants with ADHD scored significantly higher than POTS patients and the 
control subjects in all of the subscales measured.  The ADHD Behavior Checklist for Adults 
measured symptoms both in childhood and in the past six months.  Significant results showed 
that POTS patients experienced less symptoms in childhood in comparison to those with ADHD 
but no significant difference in comparison to the control group.  However, for symptoms within 
the past 6 months, POTS patients showed significantly greater symptoms of inattention and 
hyperactivity in comparison with the control group but still less than those with ADHD. 
 Overall, Vidya Raj et al. (2009) found POTS patients to have no increased likelihood of 
developing a depression or anxiety related disorder.  However, POTS patients did display a score 
indicating mild depression.  Vidya Raj et al. (2009) discussed the possibility that this finding 
could be due to the difficulties associated with living with chronic illness.  It was noted, that the 
quality of life that POTS patients experience has been compared with other chronic diseases 
including heart failure and chronic obstructive pulmonary disease.  Similarly, POTS patients did 
display scores indicating higher levels of anxiety on one scale, however the discussion on this 
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was that POTS patients experience physical symptoms that could be attributed to anxiety but 
instead is due to the pathology of the postural orthostatic tachycardia syndrome.  Therefore, it 
was suggested that the anxiety symptoms are physically rather than psychologically based.  
Further studies using objective measures were recommended due to subjective nature of data 
collected and small sample size. 
Diurnal Variability in Heart Rate and Blood Pressure 
 Brewster et al. (2012) conducted a study to examine diurnal variability within two 
groups, a POTS group (N=54) and a healthy control group (N=26).  Those participants in the 
POTS group had not taken any medications affecting hemodynamics for at least five half-lives of 
the medication.  Fludrocortisone was discontinued, specifically, for at least five days prior to 
beginning the study.  The healthy control group also did not take any medications affecting 
hemodynamics.  Significance was identified as P<0.05. 
 An automatic BP monitor was used to obtain orthostatic BP and HR measurements the 
night of admission to the research center and then again the next morning (Brewster et al., 2012).  
Orthostatic measurements in both instances were taken supine and then after standing for five 
minutes.  Both POTS patients and healthy controls experienced significantly greater orthostatic 
tachycardia and higher standing heart rates in the morning than in the evening.  Supine HR 
measurements were unchanged between the evening and morning in the POTS patients while the 
healthy controls had a slight decrease in supine HR for the morning check.  The only significant 
difference in BP was a slight decline in SBP for both POTS and control subjects in the morning 
measurement in comparison with the evening. 
 Interestingly, a higher percentage of participants, both POTS and healthy controls, met 
the orthostatic HR criteria (≥30 bpm) of POTS in the morning than did in the evening (Brewster 
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et al., 2012).  This finding suggests that this phenomenon is a normal finding that is simply 
increased in POTS patients.  Brewster et al. (2012) discussed that consideration should be given 
to standardizing time of day for data collection in diagnosing POTS.  More patients could 
possibly be accurately diagnosed if measurement time was standardized to morning. 
Propranolol for Symptom Improvement 
 Satish Raj et al. (2009) conducted a study utilizing a randomized crossover design to 
examine the efficacy of propranolol versus placebo in improving symptom load in POTS 
patients.  Two protocols were used, some patients being eligible to complete both protocols.  In 
the 1
st
 protocol (N=54), propranolol 20 mg was compared with placebo, given on separate days 
within a randomized single-blind fashion.  The 2
nd
 protocol (N=18) involved comparison of 
propranolol 20 mg versus 80 mg, again single-blind, randomized, and given on separate days.  
For both protocols, vital signs were monitored immediately before and hourly for four hours 
after administration of the study drug.  Each vital sign measurement was taken with the patient 
seated and after standing for 10 minutes and was collected via a Dinamap that automatically and 
digitally input the measurements into the computer database.  Nine symptoms were assessed 
immediately before study drug administration and after administration of drug at the two and 
four hour marks.  Patients rated the severity of each of the nine symptoms on a scale of 0-10, 
with 0 being the absence of symptom.  Significant results were defined as P<0.05. 
 In protocol #1, significantly lower heart rate was found with propranolol 20 mg versus 
placebo at the one hour post drug administration for both the sitting and standing measurement 
and for the remainder of the four hour study period (Satish Raj et al., 2009).  Similarly, the SBP 
was significantly lowered after propranolol 20 mg versus placebo at the one hour check for 
standing, and continuing for three hours, and at the two hour mark for sitting, and continuing for 
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the full four hours.  The sitting and standing DBP were lowered as well.  Overall, there was a 
significant change (decrease) in HR following administration of 20 mg propranolol versus 
placebo.  In protocol #2, the standing heart rate and SBP were significantly lower with the 80 mg 
versus the 20 mg starting at the one hour check and continuing for the remainder of the four hour 
collection time.  There was not any significant difference in sitting HR, SBP, or DBP readings 
between the 20 mg and 80 mg groups.  In overall change for HR, SBP, or DBP, the only 
significant change was seen in HR decrease at the one hour check, with a greater change 
following 80 mg administration versus the 20 mg, and continuing for the full four hours. 
 Based on the symptom severity rating scores, propranolol 20 mg was found to decrease 
total symptom load in comparison with placebo (Satish Raj et al., 2009).  Interestingly, the low 
dose propranolol (20 mg) was also found to decrease total symptom load, overall, more than the 
high dose (80 mg).  This finding is significant because it implies that lower dose propranolol is 
more effective at decreasing both HR and symptom load versus a higher dose.  Satish Raj et al. 
(2009) discussed the theory that POTS patients may need some elevation in HR in order to 
preserve optimal cardiac output and perfusion.  It was suggested that the commonly reported 
failure of beta-blocker trial in POTS patients may be due to commonly overprescribed dose.  
There were some reported limitations.  The principle investigator was blind to the study drug 
until after the data collection was finished, but the nurse administering drug and collecting data 
was not.  Therefore, it was single-blind only.  Satish Raj et al. (2009) stated, however, that this 
possible limitation was corrected by use of automatic collection devices that input data into the 
database directly.  Furthermore, the symptoms were reported by the patient who was blind to 
study drug.  Further research could be done with larger sample size for protocol #2 and a longer 
duration for follow-up after drug administration. 
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Chapter 3 DISCUSSION OF PROJECT 
Website 
 My personal experience with POTS was my inspiration and motivation for developing 
this project.  Having had POTS for over 10 years, and only recently getting progressively worse, 
I feel driven to help educate and build awareness in the public and help provide answers and 
support to other POTS patients.  This is an ongoing project, meaning that content and layout may 
change and develop over the coming weeks and months.  I am committed to keeping my website 
(lifegonetopots.com) active for a minimum of one year, at which time I will analyze the 
effectiveness and helpfulness it has proven and then reevaluate at that point.  The following 
headings and content is what can be found currently on my website: 
Home 
 Dysautonomia is the medical word used to describe various conditions in which the 
autonomic nervous system malfunctions.  The autonomic nervous system is the branch of the 
nervous system that controls all of the functions in the body that are not under our conscious 
control:  digestion, sweating, heart rate, blood pressure, etc.  Postural Orthostatic Tachycardia 
Syndrome (POTS) is one type of dysautonomia which affects heart rate and the body’s ability to 
adapt when a person moves around and changes position.  Many POTS patients experience other 
symptoms in addition to abnormally high heart rate when standing.  Some patients have 
difficulty even completing routine activities of daily living.  I have heard several POTS patients, 
including myself, make the comparison of living with POTS being like the waves of the ocean or 
a roller coaster.  Each day is different and it is difficult not knowing what to expect day-to-day 
and even hour-to-hour or minute-to-minute.  Whether you or someone you love has POTS, or 
you are a healthcare provider or other interested individual, please explore the rest of my site for 
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more information about POTS, helpful resources, and to take a glimpse into my own experience 
of living with POTS.  I hope you will find this website helpful and encouraging! 
All About POTS 
 Who, What, and Why.  This section currently has an abbreviated version of the 
information covered in Chapter 1.  Because it was already covered previously in this paper, 
please see Appendix A for the full version that is currently displayed on the website.  The 
expanded version found earlier in this paper may eventually be the content that is included on the 
website.  There is often a fine line between providing deep enough information to be helpful and 
providing so much that it just muddles the understanding.  That line will eventually be found on 
the website. 
 Diagnosis.  Diagnosis of POTS is done either through a tilt table test or, at times, bedside 
orthostatic vital signs.  The heart rate must increase at least 30 beats per minute within the first 
10 minutes of standing after the patient changes position from lying to standing (Conner, Sheikh, 
& Grubb, 2012; Grubb et al., 2006; Grubb, 2008; Raj, 2006).  Diagnosis is made on somewhat of 
an exclusionary basis, meaning that all factors must be considered before diagnosing POTS and 
it cannot be diagnosed on a single episode of orthostatic tachycardia.  There must not be any 
acute and reversible cause of symptoms such as medications disrupting normal autonomic 
function, acute dehydration, or active bleeding (Raj, 2006).  Also, it is important for clinicians to 
consider and rule out alternate diagnoses that could be to blame before diagnosing POTS.  
Twenty-four hour holter monitor, lab (blood) tests, echocardiogram, and other testing may be 
necessary. Symptoms must be present for greater than three months (Grubb, 2008).  One other 
interesting point is that by considering so narrowly the heart rate in the diagnostic criteria, other 
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symptoms can be downplayed or forgotten (Grubb et al., 2006; Grubb, 2008).  This can leave the 
patient frustrated and feeling like answers are lacking. 
 Symptoms.  Symptoms include light-headedness, fatigue, tremor, exercise intolerance, 
syncope and near syncope, in addition to many more (Abed et al., 2012).  Due to the number of 
symptoms and expanded reference list included on the website, as well as the layout used, please 
see Appendix B for this information in its entirety. 
 Treatment/Management.  POTS is difficult to manage, since each patient lives a unique 
experience with POTS and needs an individualized plan of care.  POTS patients need to increase 
water and salt intake, aiming for 8-10 cups per day as hydration maintenance alone (Raj, 2006).  
Caution should be taken in drinking too much water, however, since the imbalance can swing in 
the opposite direction causing electrolyte imbalance and possible heart rhythm problems (Abed 
et al., 2012).  Healthcare providers can help monitor electrolyte levels and find the correct intake 
balance.  Salt should be liberalized, making sure to get at least 2-4 g per day (Conner et al., 2012; 
Grubb et al., 2006).  Some healthcare providers recommend even more.  Salt tablets are available 
if dietary intake is insufficient.   
 Use of medication such propranolol, a beta blocker, is another good treatment option.  
Research has found low dose propranolol to be helpful in reducing HR and symptoms in POTS 
patients, but care should be taken since many patients experience hypovolemia and thus issues 
with hypotension (Satish Raj et al., 2009; Abed et al., 2012).  Beta-blockers can worsen this 
problem and thus patients must be monitored for efficacy in improvement as well as 
exacerbation of signs and symptoms.  Normal saline (0.9% sodium chloride) infusions are a 
useful treatment option for providing temporary relief to patients.  This improvement is due to an 
acute load of sodium and increase in overall blood volume helping to alleviate some of the very 
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issues that cause POTS patients’ problems.  Similarly, Fludrocortisone pills can be prescribed to 
aid the body in retaining sodium and water.  The improvement in symptoms is through the same 
principal of increasing blood volume. 
 Compression stockings can be helpful in helping reduce the blood pooling.  Waist high 
compression stockings with a pressure of 30-40 mmHg are recommended (Grubb et al., 2006; 
Raj, 2006).  Exercise is also helpful.  Both aerobic and resistance training are recommended, and 
patients should aim for about 20-30 minutes of exercise at least three days per week (Grubb et al, 
2006; Raj, 2006; Abed et al., 2012).  Exercise should be started slow and increased as tolerated, 
using target heart rate and personal tolerance as a guide.  Persistence is crucial, however. 
 Overall, management of this condition is very individualized with many possible 
treatment plans, not all of which were discussed here.  POTS cannot be cured, as such, but it can 
be managed.  Some patients respond better than others to management, but all patients deserve 
informed choices of the available and appropriate options.  Not all management options are 
appropriate for every case, so healthcare provider direction and prescription is important. 
Current Research 
 This page displays the information from the studies reviewed in Chapter 2 of this paper.  
Additional studies may be added at some point in the future.  The layout and website view of this 
information can be found in Appendix C but is identical, with the exceptions of the first 
paragraph and hyperlinks to the articles, to what is displayed in Chapter 2 of this paper. 
My Personal Experience 
 This will be a blog style section with thoughts, ideas, and experiences from my personal 
journey with POTS.  The purpose of this section is to help encourage others and let them know 
that they are not alone and that someone else is experiencing similar difficulties.  I will also share 
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suggestions and advice, both from my personal journey and from any questions or comments that 
I may receive as a result of this website.  Please see Appendix D for the current content of this 
page, with the exception of different background coloring and an embedded video.  It will 
expand and develop over the coming weeks and months as it progresses further. 
Resources 
 This section has a hyperlinked list of helpful resources.  Resources include: 
Dysautonomia International, Dysautonomia Information Network (DINET), National 
Dysautonomia Research Foundation, Vanderbilt Autonomic Dysfunction Center, PMC US 
National Library of Medicine, National Institutes of Health to search for current articles and 
research, a link to find compression stockings from BrightLifeGo, and a link (www.nuun.com)  
to a product called “nuun electrolyte enhanced drink tabs” that can be added to water as an 
alternative to other sports drinks.  Other resources will be added as I communicate with other 
patients I know and learn about various products or suggestions that work well for them. 
Future Plans 
 As already discussed throughout Chapter 3, the website will continue to develop and 
change over the coming months as I get a feel for what is helpful and what might be lacking.  In 
the past I have kept up a YouTube channel with videos I have recorded commenting on my 
experiences with POTS.  I got a good number of views as well as comments and questions with 
that and am considering incorporating something like that again in connection with the website.  
Also, I have designed and printed postcard sized cards that can be given or mailed to patients, 
healthcare providers, family members, and others that might be interested in learning more.  The 
design is a picture description of POTS that I designed using Microsoft Word.  On the back are a 
small quick view calendar, a short description of who might be interested in visiting my website, 
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and a small logo including the URL to my website (see Appendix E).  My intention is that my 
website can be a solid starting point toward learning more, and visitors can utilize the Resources 
page to visit other links that have additional and different information and resources.  I also was 
asked to present my project during grand rounds at the inpatient Clinical Research Center at 
Vanderbilt in Nashville, TN, where I have also been a patient for several studies, and will 
hopefully get an opportunity to do that in the future.  I also hope to attend the 3
rd
 annual 
Dysautonomia International conference if possible.  In the coming months and years, I hope to 
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Appendix A 
Who, What, and Why                       
Postural orthostatic tachycardia syndrome (POTS) is thought to affect at least 500,000 
people in the United States alone.1 Women are affected by POTS more often than men 
with an estimate of a 4 or 5:1 female-to-male ratio.1,4,5 In order to understand the 
symptoms and treatment options for POTS, it is important to understand what is causing 
the signs and symptoms of the condition. 
What is POTS? 
Simply stated, POTS patients have a faulty autonomic nervous system that does not 
react correctly when the patient is upright. Imagine when you stand up: a healthy person 
without POTS has an autonomic nervous system that is working properly. When that 
person stands up, gravity causes a shift in the blood volume toward the lower body, and 
a slight increase in heart rate occurs to help push the blood back up.2 The autonomic 
nervous system is working well, so the body compensates very quickly and pumps the 
blood back up into the rest of the body where it belongs.  The heart rate remains stable 
with only minimal changes, and the person continues feeling well as stability and 
balance is maintained in the body. People with POTS have an autonomic nervous 
system that is not working properly. When they stand up and blood rushes into the legs, 
the body is unable to compensate correctly. This imbalance causes prolonged blood 
pooling in the legs and a significantly increased heart rate.  Since the autonomic system 
does not react properly and does not pump the blood back up to the brain effectively, 
the brain and other organs soon feel the decrease in blood flow and many unpleasant 
symptoms can occur: such as lightheadedness, palpitations (feeling like your heart is 
beating really hard or fast), and feeling faint. The body continues to try and compensate 
for the faulty autonomic system and the prolonged shift in blood volume by making the 
heart beat faster. Once the patient sits and/or lies down again symptoms usually 
decrease or subside, but many POTS patients do report other varying symptoms such 
as fatigue and difficulty sleeping.3A more comprehensive list of symptoms can be found 
on the symptom page. But why does the autonomic nervous system not function 
properly? 
 




POTS can be categorized as either the primary form or the secondary form.1 Primary 
POTS is not associated with any other known disease, whereas the secondary form of 
POTS is caused by some other known underlying illness or disease.4 The primary form 
of POTS is usually caused by a peripheral autonomic neuropathy, causing the vessels 
in the periphery not to contract appropriately when the patient is upright. This “partial 
dysautonomic” form is the most common form of POTS and often occurs abruptly after 
a viral illness or some other precipitating event such as pregnancy, surgery or trauma, 
sepsis, or immunizations. The abrupt onset after these types of events has lead 
researchers to believe that this form of POTS is immune-mediated. The other type of 
“partial dysautonomic” POTS is developmentally based. Some teens seem to develop 
POTS in the adolescent years, and often times (around 80% of cases) these patients 
outgrow or make a near full recovery by the early to mid-20s. The least common form of 
primary POTS is the hyperadrenergic form. Hyperadrenergic POTS is associated with 
significantly elevated levels of norepinephrine (>600 ng/mL) while upright. These 
patients often exhibit orthostatic hypertension in addition to tachycardia. Patients often 
develop the hyperadrenergic form gradually and progressively, and this form is 
believed, at this point, to be caused by a genetic mutation causing an inappropriate 
overabundance of norepinephrine due to dysfunction of the reuptake transporter 
protein.  The body is unable to clear that norepinephrine from the intrasynaptic cleft 
leaving the patient experiencing high levels of circulating catecholamines (stress 
hormones such as norepinephrine) and resulting in symptoms of excessive sympathetic 
(fight-or-flight) activity.  Imagine if you were suddenly chased by a huge and hungry 
grizzly bear.  How would your body react?  What symptoms would you experience when 
that “fight-or-flight” reaction kicked in? Hyperadrenergic POTS patients experience that 
same type of reaction from simple and everyday precipitating factors such as standing 
up or other various triggers that set off that “fight-or-flight” cascade. 
Secondary 
Patients that have the secondary form of POTS have some other underlying illness or 
disease, such as diabetes, Sjogren’s syndrome, or Lupus.4 For instance, chronic 
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diabetes mellitus can cause peripheral neuropathy resulting in improper or absent 
peripheral autonomic “communication” thus causing the vessels to react improperly and 
the symptoms of POTS to result.4 Other conditions such as mastocytosis and mast cell 
activation syndrome (MCAS) have also been linked to POTS. 6 Mast cell disorders are 
either proliferative (too many mast cells accumulating in tissue or organs, as in 
mastocytosis) or activation based (the correct number but overactive mast cells, as in 
MCAS).7 The histamine and other substances being released cause the vessels to 
dilate causing blood pooling as in other types of POTS and the body experiences a 
hyperadrenergic type response as it deals with this perceived threat.6,7 There is 
discussion on whether the “fight-or-flight” response initiates the mast cell response or 
whether the mast cell response causes the “fight-or-flight” response. Either way, the 
result is the same. It is also important to recognize that patients experiencing the 
secondary form of POTS will experience a different symptom range than those with one 
of the primary forms. Those with the secondary forms of POTS have symptoms and 
difficulties associated with the primary or associated condition as well as POTS. Further 
reading of the references provided here, as well as other materials and the “My 
Personal Experience” page, will provide further insight into the additional symptoms and 
issues that patients can experience in addition to POTS, based on whatever underlying 
condition is present. 
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In order to understand why POTS patients experience the symptoms they do, it’s 
important to understand what POTS is. Check out the “All About POTS” tab to learn 
more. Not every person has the same combination or severity of symptoms, but the 
following is a list of possible symptoms that POTS patients experience: 
 Chronic dizziness1 
 Light-headedness1-3 
 Chest discomfort or pain1-3 
 Palpitations1-3 
 Dyspnea (difficulty breathing)3 




 Sleep difficulties3 
 Mental clouding (brain fog)1-3 
 Exercise intolerance2-3 
 Fatigue2-3 
 Pre-syncope (feeling like passing out)2-3 
 Syncope (actual fainting)2-3 
 Diaphoresis (increased amount of sweating)2 
 Blurred vision2 
 Early satiety (feeling full after only a small amount of food)2 
 Anxiety2 
 Flushing2 
 Postprandial hypotension (low blood pressure after eating)2 
 Lower back pain2 
 Aching neck and shoulders2 
 Cold hands2 
 Hypovolemia (decreased blood volume)2 
 Generalized weakness1 
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 Inappropriate sinus tachycardia1 
 Gastrointestinal or bladder disorders1 
1. Benarroch, E. Postural tachycardia syndrome: A heterogeneous and 
multifactorial disorder. Mayo Clin Proc. 2012;87(12):1214-1225. 
doi:10.1016/j.mayocp.2012.08.013 
2. Abed, H., Ball, P., & Wang, L. Diagnosis and management of postural orthostatic 
tachycardia syndrome: A brief review. J Geriatr Cardiol. 2012;9:61-67. doi: 
10.3724/SP.J.1263.2012.00061 
3. Raj, S., & Levine, B. (2013). Postural tachycardia syndrome (POTS) diagnosis 
and treatment: Basics and new developments. Retrieved from 
http://crm.cardiosource.org/Learn-from-the-Experts/2013/02/POTS-Diagnosis-and-
Treatment.aspx. Accessed October 20, 2014. 




Research is a very important element toward patients receiving appropriate care and 
treatment.  If you are a POTS patient and are interested in getting involved by 
participating in some studies, follow this link for more information on how you can get 
involved. The following are descriptions and implications of some of the recent research 
studies that have been done regarding POTS. 
Sleep and Quality of Life 
Bagai et al. (2011), of Vanderbilt University, assessed (a) health-related quality of life, 
(b) fatigue, and (c) sleep quality in POTS patients, in comparison to healthy control 
subjects, by using a series of scales and questionnaires.  A total of 90 participants were 
included in the study:  44 POTS patients who met the criteria for POTS diagnosis and 
46 healthy control subjects recruited through a research volunteer database and 
advertisements within the local campus community. 
Several tools were utilized during data collection.  Bagai et al. (2011) used the Medical 
Outcomes Study Sleep Scale comprised of 12 questions in order to assess difficulties 
within several areas of sleep:  snoring, sleep adequacy, sleep disturbance, headache, 
somnolence, and respiratory impairment.  Each area is scored on a scale of 0-100, with 
a higher score for sleep adequacy indicating improved and better sleep, and a higher 
score on any of the other areas indicating increased dysfunction.  The Epworth 
Sleepiness Scale ranging from 0 to 3, with a total possible score of 24, assesses 
subjective daytime sleepiness.  Eight common situations of daily living are presented 
and respondents must indicate the likeliness of sleeping in each situation.  Responses 
>10 are usually seen in individuals with diagnosed sleep disorders affecting daytime 
sleepiness, whereas responses <10 are considered normal.  The Fatigue Visual 
Analogue Scale is a one question assessment of fatigue severity and uses a scale of 0-
10, the higher responses indicating higher levels of fatigue.  The RAND-36 is a more 
general questionnaire assessing quality of life in 8 domains:  “physical functioning, role 
limitations caused by physical health problems, bodily pain, general health, emotional 
well-being, role limitations due to emotional problems, social functioning, and 
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energy/fatigue” (Bagai et al., 2011, p. 205).  A 0-100 scale is used, asking participants 
to rate in each area over the last four weeks.  Poorer quality of life is indicated by lower 
scores.  Lastly, the EuroQol was used to collect subjective rating for level of problem 
within 5 areas relating to health:  mobility, anxiety/depression, usual activities, self-care, 
and pain/discomfort.  Participants rated each as either “no problem, some/moderate 
problems, or extreme problems” but results “were analyzed as dichotomous variables 
(no problems vs. some/moderate/extreme problems)” (p. 205). 
The Medical Outcomes Sleep Scale found significantly poorer sleep adequacy and 
increased sleep difficulties in POTS patients than were found in the control 
subjects (Bagai et al., 2011).  The Epworth Sleepiness Scale found a significant 
difference between POTS patients and control subjects.  51% of POTS patients scored 
>10, indicating excessive daytime sleepiness, in comparison with 16% of control 
subjects scoring above the same mark.  The Fatigue Visual Analogue Scale found that 
a significantly higher number of POTS patients, in comparison to healthy controls, 
indicated fatigue being a major issue within the past seven days.  The RAND-36 and 
EuroQol both indicated significantly poorer “health-related quality of life” in POTS 
patients than in the control subjects.  The physical health scores were lower than were 
the mental health related scores (Bagai et al., 2011, p. 206). 
Overall, Bagai et al. (2011) found that POTS patients experience more fatigue and 
sleep related difficulties than do healthy control subjects.  Furthermore, these 
sleepiness and fatigue related difficulties are related to poorer quality of life.  
Interestingly, results showed that physical health was affected more than mental health, 
and because the control group scored worse in the snoring category, the authors have 
assumed that the self-reporting nature of the study, viewed as a possible limitation, did 
not in fact cause over-reporting of symptoms in the POTS group.  Bagai et al. 
(2011) recommend further studies on this topic and involvement of more formal and 
objective methods to further understand the findings. 
Bagai, K., Song, Y., Ling, J., Malow, B., Black, B., Biaggioni, I.,…Raj, S. (2011). Sleep 
disturbances and diminished quality of life in postural tachycardia syndrome. Journal of 
Clinical Sleep Medicine, 7(2), 204-210. 
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Inattention and Psychiatric Disorders 
Raj et al. (2009) used a cross-sectional controlled method to assess anxiety, attention, 
and mood in POTS patients (N=21) compared to ADHD participants (N=18) and normal 
control subjects (N=20) with no history of psychiatric or attention disorders.  Previously 
validated and commonly used questionnaires were used.  POTS patients met the 
diagnostic criteria for POTS, were tested while in the sitting position, were not currently 
taking any medications affecting psychiatric or autonomic function, and were 
asymptomatic during testing.  Comparisons were done between two matched groups:  
POTS patients with ADHD participants, and POTS patients with normal control subjects 
with no history of attention or psychiatric diagnoses.  Significance was set at the P<0.05 
level. 
Results showed that POTS patients did not experience significantly higher rates of 
anxiety disorders in comparison to the normal control subjects or those with ADHD (Raj 
et al., 2009).  Similarly, POTS patients did not show a greater “lifetime prevalence of 
major depressive disorder” in comparison with the normal control subjects (p. 4).  The 
ADHD participants, however, did show higher incidence of depressive disorders than 
both the normal control group and the POTS patients.  POTS patients also showed no 
significant differences in substance dependence and abuse in comparison to the normal 
control group. 
Significant differences were found among scores on the second edition of the Beck 
Depression Inventory for degree of depression symptoms between the groups for (Raj 
et al., 2009).  Both POTS patients and ADHD participants scored higher in comparison 
with the control group for “magnitude of current depression symptoms” (p. 4).  The 
difference between POTS and ADHD scores, however, were not significantly different.  
The Beck Anxiety Inventory showed significantly higher scores in POTS patients in 
comparison with both the control subjects and those with ADHD.  The Anxiety 
Sensitivity Index showed significantly higher fear of anxiety related symptoms in the 
ADHD and POTS groups in comparison with the normal controls, however in 
comparison with the general population, POTS patients actually scored lower and 
ADHD subjects still scored higher. 
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The Connors Adult ADHD Rating Scale showed that POTS patients experienced 
significantly higher scores in comparison with the control subjects in three areas:  
inattention/memory problems, ADHD score, and ADHD index (Raj et al., 2009).  
However, those participants with ADHD scored significantly higher than POTS patients 
and the control subjects in all of the subscales measured.  The ADHD Behavior 
Checklist for Adults measured symptoms both in childhood and in the past six months.  
Significant results showed that POTS patients experienced less symptoms in childhood 
in comparison to those with ADHD but no significant different in comparison to the 
control group.  However, for symptoms within the past 6 months, POTS patients 
showed significantly greater symptoms of inattention and hyperactivity in comparison 
with the control group but still less than those with ADHD. 
Overall, Raj et al. (2009) found POTS patients to have no increased likelihood of 
developing a depression or anxiety related disorder.  However, POTS patients did 
display a score indicating mild depression.  Raj et al. (2009) discussed the possibility 
that this finding could be due to the difficulties associated with living with chronic 
illness.  It was noted, that the quality of life that POTS patients experience has been 
compared with other chronic diseases including heart failure and chronic obstructive 
pulmonary disease.  Similarly, POTS patients did display scores indicating higher levels 
of anxiety on one scale, however the discussion on this was that POTS patients 
experience physiological physical symptoms that could be attributed to anxiety but 
instead is due to the pathology of the postural orthostatic tachycardia syndrome.  
Therefore, it was suggested that the anxiety symptoms are physically rather than 
psychologically based.  Further studies using objective measures were recommended 
due to subjective nature of data collected and small sample size. 
Raj, V., Haman, K., Raj, S., Byrne, D., Blakely, R., Biaggioni, I.,…Shelton, R. (2009). 
Psychiatric profile and attention deficits in postural tachycardia syndrome. Journal of 
neurology, neurosurgery, and psychiatry, 80(3), 339-344. doi: 
10.1136/jnnp.2008.144360 
Diurnal Variability in Heart Rate and Blood Pressure 
Brewster et al. (2012) conducted a study to examine diurnal variability within two 
groups, a POTS group (N=54) and a healthy control group (N=26).  Those participants 
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in the POTS group had not taken any medications affecting hemodynamics for at least 
five half-lives of the medication.  Fludrocortisone was discontinued, specifically, for at 
least five days prior to beginning the study.  The healthy control group also did not take 
any medications affecting hemodynamics.  Significance was identified as P<0.05. 
An automatic BP monitor was used to obtain orthostatic BP and HR measurements the 
night of admission to the research center and then again the next morning (Brewster et 
al., 2012).  Orthostatic measurements in both instances were taken supine and then 
after standing for five minutes.  Both POTS patients and healthy controls experienced 
significantly greater orthostatic tachycardia and higher standing heart rates in the 
morning than in the evening.  Supine HR measurements were unchanged between the 
evening and morning in the POTS patients while the healthy controls had a slight 
decrease in supine HR for the morning check.  The only significant difference in BP was 
a slight decline in SBP for both POTS and control subjects in the morning measurement 
in comparison with the evening. 
Interestingly, a higher percentage of participants, both POTS and healthy controls, met 
the orthostatic HR criteria (≥30 bpm) of POTS in the morning than did in the 
evening (Brewster et al., 2012).  This finding suggests that this phenomenon is a normal 
finding that is simply increased in POTS patients.  Brewster et al. (2012) discussed that 
consideration should be given to standardizing time of day for data collection in 
diagnosing POTS.  More patients could possibly be accurately diagnosed if 
measurement time was standardized to morning. 
Brewster, J., Garland, E., Biaggioni, I., Black, B., Ling, J., Shibao, C.,…Raj, S. (2012). 
Diurnal variability in orthostatic tachycardia: Implications for postural tachycardia 
syndrome. Clinical science, 122(1), 25-31. doi: 10.1042/CS20110077 
Propranolol for Symptom Improvement 
Raj et al. (2009) conducted a study utilizing a randomized crossover design to examine 
the efficacy of propranolol versus placebo in improving symptom load in POTS 
patients.  Two protocols were used, some patients being eligible to complete both 
protocols.  In the 1stprotocol (N=54), propranolol 20 mg was compared with placebo, 
given on separate days within a randomized single-blind fashion.  The 2nd protocol 
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 34 
 
(N=18) involved comparison of propranolol 20 mg versus 80 mg, again single-blind, 
randomized, and given on separate days.  For both protocols, vital signs were 
monitored immediately before and hourly for four hours after administration of the study 
drug.  Each vital sign measurement was taken with the patient seated and after 
standing for 10 minutes and was collected via a Dinamap that automatically and digitally 
input the measurements into the computer database.  Nine symptoms were assessed 
immediately before study drug administration and after administration of drug at the two 
and four hour marks.  Patients rated the severity of each of the nine symptoms on a 
scale of 0-10, with 0 being the absence of symptom.  Significant results were defined as 
P<0.05. 
In protocol #1, significantly lower heart rate was found with propranolol 20 mg versus 
placebo at the one hour post drug administration for both the sitting and standing 
measurement and for the remainder of the four hour study period (Raj et al., 2009).  
Similarly, the SBP was significantly lowered after propranolol 20 mg versus placebo at 
the one hour check for standing, and continuing for three hours, and at the two hour 
mark for sitting, and continuing for the full four hours.  The sitting and standing DBP 
were lowered as well.  Overall, there was a significant overall change (decrease) in HR 
following administration of 20 mg propranolol versus placebo.  In protocol #2, the 
standing heart rate and SBP was significantly lower with the 80 mg versus the 20 mg 
starting at the one hour check and continuing for the remainder of the four hour 
collection time.  There was not any significant difference in sitting HR, SBP, or DBP 
readings between the 20 mg and 80 mg groups.  In overall change for HR, SBP, or 
DBP, the only significant change was seen in HR decrease at the one hour check, with 
a greater change following 80 mg administration versus the 20 mg, and continuing for 
the full four hours. 
Based on the symptom severity rating scores, propranolol 20 mg was found to decrease 
total symptom load in comparison with placebo (Raj et al., 2009).  Interestingly, the low 
dose propranolol (20 mg) was also found to decrease total symptom load, overall, more 
than the high dose (80 mg).  This finding is significant because it implies that lower dose 
propranolol is more effective at decreasing both HR and symptom load versus a higher 
dose.  Raj et al. (2009)discussed the theory that POTS patients may need some 
elevation in HR in order to preserve optimal cardiac output and perfusion.  It was 
suggested that the commonly reported failure of beta-blocker trial in POTS patients may 
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be due to commonly overprescribed dose.  There were some reported limitations.  The 
principle investigator was blind to the study drug until after the data collection was 
finished, but the nurse administering drug and collecting data was not.  Therefore, it was 
single-blind only.  Raj et al. (2009) stated, however, that this possible limitation was 
corrected by use of automatic collection devices that input data into the database 
directly.  Furthermore, the symptoms were reported by the patient who was blind to 
study drug.  Further research could be done with larger sample size for protocol #2 and 
a longer duration for follow-up after drug administration. 
Raj, S., Black, B., Biaggioni, I., Paranjape, S., Ramirez, M., Dupont, W., & Robertson, 
D. (2009). Propranolol decreases tachycardia and improves symptoms in the postural 
tachycardia syndrome (POTS): Less is more. Circulation, 120(9), 725-734. doi: 
10.1161/CIRCULATIONAHA.108.846501 
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Appendix D 
Tips for Living with POTS 
Enjoy this video I recently created. More posts to come soon, so check back in! 
October 24, 2014 This video is embedded at this point:  http://youtu.be/AM652i2redM 
Welcome! 
October 24, 2014My Personal Experience Edit 
Welcome! I look forward to adding posts as time goes along and do plan on giving you more 
details about my experience with POTS.  For now, know that I have lived with POTS for nearly 
15 years and have experienced “good” days and very bad days. I want to share my experiences, 
thoughts, struggles, and advice with you so hopefully it will benefit at least one other person out 
there that may be having similar problems. Know that you are not alone! Don’t hesitate to 
contact me if you have any questions or thoughts you’d like to share. 
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 37 
 
Appendix E 
  
 
